Grazia Arpino
Grazia Arpino
Verified email at
Cited by
Cited by
Progesterone receptor status significantly improves outcome prediction over estrogen receptor status alone for adjuvant endocrine therapy in two large breast cancer databases
VJ Bardou, G Arpino, RM Elledge, CK Osborne, GM Clark
Journal of clinical oncology 21 (10), 1973-1979, 2003
Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome
G Arpino, VJ Bardou, GM Clark, RM Elledge
Breast cancer research 6 (3), 1-8, 2004
Estrogen receptor–positive, progesterone receptor–negative breast cancer: association with growth factor receptor expression and tamoxifen resistance
G Arpino, H Weiss, AV Lee, R Schiff, S De Placido, CK Osborne, ...
Journal of the National Cancer Institute 97 (17), 1254-1261, 2005
Crosstalk between the estrogen receptor and the HER tyrosine kinase receptor family: molecular mechanism and clinical implications for endocrine therapy resistance
G Arpino, L Wiechmann, CK Osborne, R Schiff
Endocrine reviews 29 (2), 217-233, 2008
Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy
X Cui, R Schiff, G Arpino, CK Osborne, AV Lee
Journal of clinical oncology 23 (30), 7721-7735, 2005
A meta-analysis on the interaction between HER-2 expression and response to endocrine treatment in advanced breast cancer
M De Laurentiis, G Arpino, E Massarelli, A Ruggiero, C Carlomagno, ...
Clinical cancer research 11 (13), 4741-4748, 2005
HER-2 amplification, HER-1 expression, and tamoxifen response in estrogen receptor-positive metastatic breast cancer: a southwest oncology group study
G Arpino, SJ Green, DC Allred, D Lew, S Martino, CK Osborne, ...
Clinical cancer research 10 (17), 5670-5676, 2004
Adenoid cystic carcinoma of the breast: molecular markers, treatment, and clinical outcome
G Arpino, GM Clark, S Mohsin, VJ Bardou, RM Elledge
Cancer 94 (8), 2119-2127, 2002
Premalignant and in situ breast disease: biology and clinical implications
G Arpino, R Laucirica, RM Elledge
Annals of internal medicine 143 (6), 446-457, 2005
Treatment of human epidermal growth factor receptor 2–overexpressing breast cancer xenografts with multiagent HER-targeted therapy
G Arpino, C Gutierrez, H Weiss, M Rimawi, S Massarweh, L Bharwani, ...
Journal of the National Cancer Institute 99 (9), 694-705, 2007
Treatment of triple negative breast cancer (TNBC): current options and future perspectives
M De Laurentiis, D Cianniello, R Caputo, B Stanzione, G Arpino, S Cinieri, ...
Cancer treatment reviews 36, S80-S86, 2010
Advanced concepts in estrogen receptor biology and breast cancer endocrine resistance: implicated role of growth factor signaling and estrogen receptor coregulators
R Schiff, SA Massarweh, J Shou, L Bharwani, G Arpino, M Rimawi, ...
Cancer chemotherapy and pharmacology 56 (1), 10-20, 2005
Endocrine responsiveness: understanding how progesterone receptor can be used to select endocrine therapy
CK Osborne, R Schiff, G Arpino, AS Lee, VG Hilsenbeck
The Breast 14 (6), 458-465, 2005
Clinical and biologic features of triple-negative breast cancers in a large cohort of patients with long-term follow-up
L Malorni, PB Shetty, C De Angelis, S Hilsenbeck, MF Rimawi, R Elledge, ...
Breast cancer research and treatment 136 (3), 795-804, 2012
Human epidermal growth factor receptor 2 (HER2)-positive and hormone receptor-positive breast cancer: new insights into molecular interactions and clinical implications
F Montemurro, S Di Cosimo, G Arpino
Annals of Oncology 24 (11), 2715-2724, 2013
Lobular neoplasia on core‐needle biopsy—Clinical significance
G Arpino, DC Allred, SK Mohsin, HL Weiss, D Conrow, RM Elledge
Cancer 101 (2), 242-250, 2004
Circulating tumor cells in immunohistochemical subtypes of metastatic breast cancer: lack of prediction in HER2-positive disease treated with targeted therapy
A Giordano, M Giuliano, M De Laurentiis, G Arpino, S Jackson, BC Handy, ...
Annals of oncology 23 (5), 1144-1150, 2012
Perspective on circulating tumor cell clusters: why it takes a village to metastasize
M Giuliano, A Shaikh, HC Lo, G Arpino, S De Placido, XH Zhang, ...
Cancer research 78 (4), 845-852, 2018
Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype
L Gerratana, D Basile, G Buono, S De Placido, M Giuliano, S Minichillo, ...
Cancer treatment reviews 68, 102-110, 2018
Gene expression profiling in breast cancer: a clinical perspective
G Arpino, D Generali, A Sapino, L Del Matro, A Frassoldati, ...
The Breast 22 (2), 109-120, 2013
The system can't perform the operation now. Try again later.
Articles 1–20